Dr. Michael Ammirati, MD

Dr. Ammirati practices at Schwarz & Ammirati Medical Associates in New York, New York.

Dr. Ammirati's NPI, 1598845349, was assigned on October 16, 2006. Dr. Ammirati graduated from Renaissance School of Medicine at Stony Brook University in 1992. Dr. Ammirati holds New York license 195767.

Dr. Ammirati's primary practice is Schwarz & Ammirati Medical Associates, at 205 E 76th St Fl M2 Fl M2, New York, NY 10021-2147. The practice phone is (212) 472-4802.

Dr. Ammirati's primary practice is Schwarz & Ammirati Medical Associates in New York, New York. The medical group on file is Schwarz and Ammirati Gastroenterology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ammirati practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ammirati's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ammirati is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Ammirati is licensed in New York.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, gastroduodenitis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Ammirati treats.

CMS data shows 58 Medicare services from Dr. Ammirati across 2 procedure codes in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $4,765 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Dr. Ammirati in 2024. The largest group is 65 to 74, with 21 patients. 69% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ammirati's median patient age at 55, with 36% women.

In 2024, Dr. Ammirati wrote 259 Medicare Part D claims for 93 patients. 85% of them were for generic drugs. CMS names the drug for 190 of them, across 5 drugs with 11 or more claims each, at $12,024 in total drug cost. In 2023, CMS named 419 claims across 9 drugs.

Dr. Ammirati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ammirati as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 550 general payments to Dr. Ammirati from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Bausch Health Americas, Inc. paid the most, $2,813.

Dr. Ammirati graduated from Renaissance School of Medicine at Stony Brook University in 1992.

Dr. Ammirati is in network with 9 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.